Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
biotechdaily.com
Genomics/Proteomics
Features Subscription Partner Sites Journal Info
PZ HTL SAGLOBETECH PUBLISHING

Pancreatic Cells Derived from Human Embryonic Stem Cells Cure Diabetes in Rodent Models

By BiotechDaily International staff writers
Posted on 12 Jul 2012


Commercially available human embryonic stem cells (hESCs) have been induced to differentiate into fully functional pancreatic beta cells that were capable of restoring insulin production and regularizing glucose metabolism in two different rodent diabetes models.

Investigators at the University of British Columbia (Vancouver, Canada) and their colleagues at the biotechnology firm BetaLogics (Raritan, NJ, USA) developed a protocol to differentiate commercially available human embryonic stem cells (hESCs) in vitro into a highly enriched PDX1+ pancreatic progenitor cell population. These cells progressed in vivo into mature pancreatic endocrine cells.

Immature pancreatic precursor cells were transplanted into immunodeficient mice with streptozotocin-induced diabetes. Glycemia was initially controlled with exogenous insulin; however, as insulin levels derived from the grafted stem cells increased over time, the mice were weaned from the insulin. Glucose metabolism was eventually regulated by meal and glucose challenges. Similar differentiation of pancreatic precursor cells was observed after transplant into immunodeficient rats.

Additional details published in the June 27, 2012, online edition of the journal Diabetes revealed that throughout the in vivo maturation period hESC-derived endocrine cells exhibited gene and protein expression profiles that were remarkably similar to that of cells in the developing human fetal pancreas.

"We are very excited by these findings, but additional research is needed before this approach can be tested clinically in humans," said senior author Dr. Timothy Kieffer, professor of cellular and physiological sciences at the University of British Columbia. "The studies were performed in diabetic mice that lacked a properly functioning immune system that would otherwise have rejected the cells. We now need to identify a suitable way of protecting the cells from immune attack so that the transplant can ultimately be performed in the absence of any immunosuppression."

Related Links:
University of British Columbia
BetaLogics




Constant Climate Chamber
Constant Climate Chamber
Spectrometer
Spectrometer
Lab Centrifuge
Lab Centrifuge

More Products

Latest Genomics/Proteomics News

LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured Whitepaper
Veolia WATER:
Why pure water is important in modern chromatography

Download Whitepaper
Featured Video
BioTek:

View Video
Events
The 23rd Annual Scientific Meeting
09 Jul 2013 - 10 Jul 2013


27th Annual Symposium of the Protein Society
20 Jul 2013 - 24 Jul 2013


AACC 2013 – Annual Meeting of the American Association for Clinical Chemistry
28 Jul 2013 - 01 Aug 2013


More events
Latest Issue

View Digital Edition
Subscribe / Renew
GLOBETECH PUBLISHING'
PZ HTL SA
VISION-SCIENCES, INC.
  biotechdaily.com Copyright © 2000-2013 Globetech Media. All rights reserved.
Privacy Policy